𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Secondary orgasmic dysfunction. I. Analysis and strategies for treatment

✍ Scribed by Kevin B. McGovern; Rita C. Stewart; Joseph LoPiccolo

Publisher
Springer US
Year
1975
Tongue
English
Weight
577 KB
Volume
4
Category
Article
ISSN
0004-0002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel strategies and therapeutics for th
Novel strategies and therapeutics for the treatment of prostate carcinoma
✍ Michael J. Morris; Howard I. Scher πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 222 KB πŸ‘ 2 views

An increased understanding of the biology of prostate carcinoma has led to the clinical evaluation of mechanism-based and targeted therapies. Modulating the immune system has been pursued through the use of both active and passive immunity as well as the ex vivo genetic manipulation of effector cell

Optimal treatment for severe neurogenic
Optimal treatment for severe neurogenic bowel dysfunction after chronic spinal cord injury: a decision analysis
✍ J. C. Furlan; D. R. Urbach; M. G. Fehlings πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 314 KB πŸ‘ 2 views

## Abstract ## Background When conservative management fails in patients with chronic spinal cord injury (SCI) and neurogenic bowel dysfunction, clinicians have to choose from a variety of treatment options which include colostomy, ileostomy, Malone anterograde continence enema (MACE) and sacral a

Unilateral versus bilateral stage I neur
Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction
✍ Khanh Pham; Michael L. Guralnick; R. Corey O'Connor πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 77 KB

## Abstract ## Aims To determine if bilateral S3 lead placement during the stage I trial period improves the β€œsuccess” rate for advancing to stage II (permanent) sacral neuromodulator placement. ## Methods A retrospective chart review of 124 (20 male and 104 female) patients undergoing stage I s